Novartis buys Chinook for US$3.2-billion, latest in string of big exits for Canadian biotechs

Swiss drug giant will pay US$40 a share for Chinook; shareholders could receive an additional US$4 a share if further milestones are reached

Related Keywords

Vancouver ,British Columbia ,Canada ,Switzerland ,Bluerock ,Nova Scotia ,Japan ,Swiss ,Antonia Borovina ,Muddy Waters ,Eric Dobmeier ,Vasant Narasimhan ,Bayer Ag ,Trillium Therapeutics Inc ,Bellus Health Inc ,Clementia Pharmaceuticals Inc ,Novo Nordisk ,Baylis Medical Co ,Repare Therapeutics Inc ,Nicolas Co ,Ventus Therapeutics Inc ,Novartis ,Morgan Stanley ,Chinook Therapeutics Inc ,Abbvie Inc ,Log Increate Free ,Chinook Therapeutics ,Nasdaq Listed Chinook ,Baylis Medical ,Bellus Health ,Bloom Burton ,Nasdaq Biotechnology ,San Francisco Based ,Versant Ventures ,Bluerock Therapeutics ,Inception Discovery ,